Your browser doesn't support javascript.
loading
Aldehyde Dehydrogenase 2 Activator Augments the Beneficial Effects of Empagliflozin in Mice with Diabetes-Associated HFpEF.
Pan, Guodong; Roy, Bipradas; Giri, Shailendra; Lanfear, David E; Thandavarayan, Rajarajan A; Guha, Ashrith; Ortiz, Pablo A; Palaniyandi, Suresh Selvaraj.
Afiliação
  • Pan G; Division of Hypertension and Vascular Research, Department of Internal Medicine, Henry Ford Health System, Detroit, MI 48202, USA.
  • Roy B; Department of Physiology, Wayne State University, Detroit, MI 48202, USA.
  • Giri S; Division of Hypertension and Vascular Research, Department of Internal Medicine, Henry Ford Health System, Detroit, MI 48202, USA.
  • Lanfear DE; Department of Physiology, Wayne State University, Detroit, MI 48202, USA.
  • Thandavarayan RA; Department of Neurology, Henry Ford Health System, Detroit, MI 48202, USA.
  • Guha A; Heart and Vascular Institute, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Ortiz PA; Center for Health Policy and Health Services Research, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Palaniyandi SS; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX 77030, USA.
Int J Mol Sci ; 23(18)2022 Sep 09.
Article em En | MEDLINE | ID: mdl-36142350
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article